QP 06 - Neurocognition and Novel Therapies in Glioma

Presentations

• 08:00am - 08:05am ET

  Introductions

  Speaker: Haley Perlow, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland
• 08:05am - 08:10am ET

  Neuroanatomic Dose Constraints for Language Preservation following Brain Radiotherapy

  Speaker: Edmund Qiao, MD - University of California San Diego, San Diego
• 08:10am - 08:15am ET

  Regional Thalamic Atrophy and Diffusion Changes Predict Neurocognitive Performance after Fractionated Brain Radiation Therapy

  Speaker: Hieu Nguyen, BS - UCSD School of Medicine, La Jolla
• 08:15am - 08:20am ET

  Pilot Study of Tumor Treating Fields for Brainstem Gliomas

  Speaker: James Janopaul-Naylor, MD - Memorial Sloan Kettering Cancer Center, New York
• 08:20am - 08:25am ET

  Neurocognitive Decline Occurs after Cranial Irradiation Independent of Tumor Infiltration and Chemotherapy: A Prospective Neurocognitive and Functional MRI Study

  Speaker: Zhihua Liu, PhD - Washington University School of Medicine in St Louis, St. Louis
• 08:25am - 08:30am ET

  Patterns of Failure after 18F-DOPA PET and MRI-Guided Hypofractionated Proton Therapy in Older Adults with Glioblastoma

  Speaker: Diego Toesca, MD - Mayo Clinic Arizona, Phoenix
• 08:30am - 08:35am ET

  Plasma and CSF Liquid Biopsy Identifies Methylomic Differences between Radiation Necrosis and Recurrence in Glioblastoma

  Speaker: Taylor Weiskittel, MD, PhD, MS - Mayo Clinic, Scottsdale
• 08:35am - 08:55am ET

  Questions & Answers

  Speaker: Tony Wang, MD, FASTRO - Columbia University, New York
• 08:55am - 09:00am ET

  Closing

  Speaker: Haley Perlow, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland